Successes and Challenges of Vaccines to Prevent HPV-associated Cancers
John T. Schiller, Ph.D.
National Cancer Institute
National Institutes of Health
Dr. John T. Schiller received his bachelor’s degree in Molecular Biology from the University of Wisconsin, Madison in 1975, and his master’s and Ph.D. degrees in Microbiology from the University of Washington, Seattle, in 1978 and 1982, respectively. He is currently a NIH Distinguished Investigator and Section Chief in the Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Successes and Challenges of Vaccines to Prevent HPV-associated CancersBy: John T. Schiller, Ph.D.
View the NIH VideoCast
In his 35 years at the NCI, Dr. Schiller has studied various aspects of papillomavirus molecular biology, immunology, and epidemiology. The laboratory headed by Dr. Schiller and Dr. Lowy led in the discovery, characterization, and clinical testing of virus-like particle (VLP) vaccines to prevent the HPV infections that cause cervical and other cancers. They have facilitated technology transfer to potential HPV vaccine manufactures in developing countries and provided leadership in promoting global public health issues related to the implementation of HPV vaccination. They have received numerous awards for this work including the 2007 Sabin Gold Medal Award, the 2014 National Medal of Technology and Innovation, and the 2017 Lasker~DeBakey Clinical Medical Research Award. Dr. Schiller’s current interests include basic studies of papillomavirus virion assembly and infection, the development of 2nd generation HPV vaccines, and vaccines and therapies for other infectious diseases and cancers.
A special keynote lecture became part of the NCI Summer Curriculum in Cancer Prevention in 2000. This lecture will be held on Tuesday, July 24, 2018 at 1:00p.m. at NIH Main Campus, Natcher Auditorium, Building 45 in Bethesda, MD.